+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement



Budd-Chiari syndrome caused by obstruction of the hepatic inferior vena cava: immediate and 2-year treatment results of transluminal angioplasty and metallic stent placement



Cardiovascular and Interventional Radiology 19(1): 32-36



To assess the usefulness of percutaneous transluminal angioplasty (PTA) and expandable metallic stent (EMS) placement for treatment of Budd-Chiari syndrome (BCS). Thirty-two patients with BCS were treated by PTA alone or by PTA and EMS placement. Among the 32 patients, a membranous obstruction was found in 24 and a segmental stenosis or occlusion in 8 patients. The follow-up period for PTA was 38-68 months (mean 52.2 months); for EMS it was 20-36 months (mean 24.3 months). Twenty-one patients underwent PTA as the primary treatment. Of these, one patient died of disseminated intravascular coagulation shortly after the procedure; 20 had good to excellent initial angiographic and clinical results. Of the 20, restenosis or reocclusion developed in 10 patients (48%), all before 27 months; 8 patients (38%) became symptomatic, and 2 remained symptom-free for a total recurrent obstruction rate of 50%. The EMS group of 17 patients included 11 patients who underwent primary stenting and 6 patients with secondary stenting after recurrence following primary PTA; restenosis was demonstrated in only 2 patients (12%). We conclude that PTA alone produces excellent short-term results and about 50% sustained patency after 2 years in patients with BCS; therefore it should remain the procedure of first choice. Stents should be reserved for primary or secondary PTA failures.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 045408528

Download citation: RISBibTeXText

PMID: 8653743

DOI: 10.1007/bf02560144


Related references

Clinical experience of percutaneous transluminal angioplasty and expandable metallic stent placement for Budd-Chiari syndrome with massive thrombus in the inferior vena cava; report of a case. Rinsho Hoshasen. Clinical Radiography 35(11): 1435-1438, 1990

Treatment of the Budd-Chiari Syndrome (BCS) caused by membranous obstruction of inferior vena cava with percutaneous transluminal angioplasty: report of an amazing relation between undiagnosed BCS and infertility. Journal of Invasive Cardiology 21(9): E166-E167, 2010

Successful treatment by percutaneous balloon angioplasty of Budd-Chiari syndrome caused by membranous obstruction of inferior vena cava: 8-year follow-up study. Journal of the American College of Cardiology 28(7): 1720-1724, 1996

Percutaneous transluminal angioplasty of inferior vena cava and hepatic veins for Budd-Chiari syndrome. Ajr. American Journal of Roentgenology 160(2): 423-424, 1993

Outcome of the Z-expandable metallic stent for Budd-Chiari syndrome and segmental obstruction of the inferior vena cava. European Journal of Gastroenterology and Hepatology 28(8): 972-979, 2017

Relief of Budd-Chiari syndrome by primary placement of a metallic stent in the inferior vena cava: Case report. Minimally Invasive Therapy & Allied Technologies 6(5-6): 487-490, 1997

Successful treatment of a patient with Budd-Chiari syndrome with main hepatic vein obstruction with percutaneous transluminal angioplasty and stent placement. Nihon Shokakibyo Gakkai Zasshi 111(9): 1811-1819, 2014

Warfarin anticoagulation before angioplasty relieves thrombus burden in Budd-Chiari syndrome caused by inferior vena cava anatomic obstruction. Journal of Vascular Surgery 52(5): 1242-1245, 2010

Staged management of Budd-Chiari syndrome caused by co-obstruction of the inferior vena cava and main hepatic veins. Hepatobiliary and Pancreatic Diseases International 12(3): 278-285, 2014

Staged management of Budd-Chiari syndrome caused by co-obstruction of the inferior vena cava and main hepatic veins. Hepatobiliary & Pancreatic Diseases International 12(3): 278-285, 2013

Budd-Chiari syndrome and membranous obstruction of the suprahepatic inferior vena cava. Treatment by percutaneous intraluminal angioplasty. Gastroenterologie Clinique et Biologique 9(1): 70-74, 1985

Application of percutaneous transluminal angioplasty and stent placement at the third hepatic porta in treatment of Budd-Chiari syndrome. Zhonghua Yi Xue Za Zhi 85(4): 240-243, 2005

Budd-Chiari syndrome with long segmental inferior vena cava obstruction: treatment with thrombolysis, angioplasty, and intravascular stents. Journal of Vascular and Interventional Radiology 3(2): 421-425, 1992

Long-term results with the use of metallic stents in the inferior vena cava for treatment of Budd-Chiari syndrome. Journal of Vascular and Interventional Radiology 5(3): 411-416, 1994

Budd chiari syndrome with membranous obstruction of inferior vena cava treatment by meso caval anastomosis and inferior vena cava to right atrium prosthesis. Gastroenterologie Clinique et Biologique 6(10): 748-751, 1982